Tatva Chintan Pharma Chem reported 43.30% decline in consolidated net profit to Rs 96.14 crore in Q4 FY24 as compared with Rs 169.54 crore posted in Q4 FY23.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Tatva Chintan Pharma Chem reported 43.30% decline in consolidated net profit to Rs 96.14 crore in Q4 FY24 as compared with Rs 169.54 crore posted in Q4 FY23.
| Subscribe To Our Free Newsletter |
